CA230996S - Formulation system - Google Patents
Formulation systemInfo
- Publication number
- CA230996S CA230996S CA230996F CA230996F CA230996S CA 230996 S CA230996 S CA 230996S CA 230996 F CA230996 F CA 230996F CA 230996 F CA230996 F CA 230996F CA 230996 S CA230996 S CA 230996S
- Authority
- CA
- Canada
- Prior art keywords
- formulation system
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202429908552 | 2024-01-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA230996S true CA230996S (en) | 2025-11-12 |
Family
ID=92970253
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA241200F Active CA241200S (en) | 2024-01-12 | 2024-06-11 | Formulation system |
| CA230996F Active CA230996S (en) | 2024-01-12 | 2024-06-11 | Formulation system |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA241200F Active CA241200S (en) | 2024-01-12 | 2024-06-11 | Formulation system |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP1781643S (en) |
| CA (2) | CA241200S (en) |
-
2024
- 2024-05-23 JP JP2024010383F patent/JP1781643S/en active Active
- 2024-06-11 CA CA241200F patent/CA241200S/en active Active
- 2024-06-11 CA CA230996F patent/CA230996S/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP1781643S (en) | 2024-10-07 |
| CA241200S (en) | 2025-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202312220D0 (en) | Formulation | |
| GB202308224D0 (en) | Formulation | |
| CA241200S (en) | Formulation system | |
| IL319149A (en) | Upadacitinib formulation | |
| GB202510110D0 (en) | Formulation | |
| GB202416618D0 (en) | Cannabidiol-based formulation | |
| GB202411714D0 (en) | Formulation | |
| GB202510902D0 (en) | System | |
| GB202510455D0 (en) | Aersospace populsion system | |
| GB202509370D0 (en) | Co-magnetometry system | |
| GB202501273D0 (en) | System | |
| GB202414356D0 (en) | Microphysiological system | |
| GB202403503D0 (en) | Wall-Cladding System | |
| GB202418989D0 (en) | Connection system | |
| GB202417097D0 (en) | New formulation | |
| GB202416909D0 (en) | New formulation | |
| CA231956S (en) | Scaffolding system | |
| CA233850S (en) | Disinfection system | |
| GB202407735D0 (en) | Novel formulation | |
| GB202508911D0 (en) | Carry system | |
| GB202413603D0 (en) | Formulation method | |
| GB202417829D0 (en) | Formulations | |
| GB202510537D0 (en) | Pharmaceutical formulation | |
| GB202318884D0 (en) | Formulation | |
| GB202316857D0 (en) | Cannabinoid-based formulation |